G
Gaetano Lombardi
Researcher at University of Naples Federico II
Publications - 378
Citations - 29556
Gaetano Lombardi is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Acromegaly & Polycystic ovary. The author has an hindex of 93, co-authored 378 publications receiving 28081 citations. Previous affiliations of Gaetano Lombardi include Parthenope University of Naples.
Papers
More filters
Journal ArticleDOI
CONSENSUS: Guidelines for Diagnosis and Therapy of MEN Type 1 and Type 2
Maria Luisa Brandi,Robert F. Gagel,Alberto Angeli,John P. Bilezikian,Paolo Beck-Peccoz,Cesare Bordi,Bernard Conte-Devolx,Alberto Falchetti,R. G. Gheri,Alfonso Libroia,Cornelius J. M. Lips,Gaetano Lombardi,Massimo Mannelli,Furio Pacini,Bruce A.J. Ponder,Frank Raue,Britt Skogseid,Guido Tamburrano,Rajesh V. Thakker,Norman W. Thompson,Paola Tomassetti,Francesco Tonelli,Samuel A. Wells,Stephen J. Marx +23 more
TL;DR: The specific RET codon mutation correlates with the MEN2 syndromic variant, the age of onset of M TC, and the aggressiveness of MTC; consequently, that mutation should guide major management decisions, such as whether and when to perform thyroidectomy.
Journal ArticleDOI
Advances in the treatment of prolactinomas.
TL;DR: A critical analysis of the efficacy and safety of the various modes of therapy available for the treatment of patients with prolactinomas with an emphasis on challenging situations is provided, a discussion of the data regarding withdrawal of medical therapy, and a foreshadowing of novel approaches to therapy that may become available in the future.
Journal ArticleDOI
Adjuvant mitotane treatment for adrenocortical carcinoma.
Massimo Terzolo,Alberto Angeli,Martin Fassnacht,Fulvia Daffara,Libuse Tauchmanovà,Pier Antonio Conton,R. Rossetto,Lisa Buci,Paola Sperone,Erika Grossrubatscher,Giuseppe Reimondo,Enrico Bollito,Mauro Papotti,Wolfgang Saeger,Stefanie Hahner,Ann Cathrin Koschker,Emanuela Arvat,Bruno Ambrosi,Paola Loli,Gaetano Lombardi,Massimo Mannelli,Paolo Bruzzi,Franco Mantero,Bruno Allolio,Luigi Dogliotti,Alfredo Berruti +25 more
TL;DR: Adjuvant mitotane treatment had a significant advantage for recurrence-free survival in patients with radically resected adrenocortical carcinoma, and temporary dose reduction was needed in 13% of patients.
Journal ArticleDOI
Growth hormone and the heart
TL;DR: Several lines of evidence have suggested that the cardiovascular abnormalities can be partially reversed by suppressing GH and IGF‐I levels in acromegaly or after GH replacement therapy in GHD patients.
Journal ArticleDOI
Effects of subclinical thyroid dysfunction on the heart.
TL;DR: Changes in cardiovascular abnormalities reported support the view that subclinical thyroid dysfunction is not a compensated biochemical change sensu strictu, and all English-language peer-reviewed reports considered were considered.